Jim Simons
BDSX icon

Jim Simons’s Biodesix BDSX Stock Holding History

Jim Simons’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173K Buy
+11,948
New +$148K ﹤0.01% 2940
2025
Q2 		– Sell
-18,535
Closed -$232K – 3556
2025
Q1 		$232K Buy
18,535
+525
+3% +$10.1K ﹤0.01% 3033
2024
Q4 		$551K Buy
18,010
+15,952
+775% +$469K ﹤0.01% 2797
2024
Q3 		$73.3K Buy
2,058
+1,503
+271% +$51.7K ﹤0.01% 3302
2024
Q2 		$17K Sell
555
-105
-16% -$3K ﹤0.01% 3396
2024
Q1 		$19K Sell
660
-1,780
-73% -$60.9K ﹤0.01% 3592
2023
Q4 		$90K Buy
2,440
+1,370
+128% +$43K ﹤0.01% 3329
2023
Q3 		$35K Sell
1,070
-635
-37% -$17.6K ﹤0.01% 3452
2023
Q2 		$42K Sell
1,705
-695
-29% -$20.8K ﹤0.01% 3644
2023
Q1 		$89K Sell
2,400
-440
-15% -$18.1K ﹤0.01% 3522
2022
Q4 		$131K Sell
2,840
-5
-0.2% -$136 ﹤0.01% 3546
2022
Q3 		$72K Buy
2,845
+15
+0.5% +$578 ﹤0.01% 3673
2022
Q2 		$93K Buy
+2,830
New +$92K ﹤0.01% 3870

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Jim Simons's BDSX Position: Q1 2026 in Review

Jim Simons opened a new position in Biodesix (BDSX) in Q1 2026: 11,948 shares worth $173K. The stake represents ﹤0.01% of the portfolio and ranks #2940 among its holdings. This is a return to the name: Jim Simons previously reported a position in BDSX as recently as Q1 2025.

Jim Simons first reported a position in BDSX in Q2 2022 and has held it in 13 quarters since. The position peaked at $551K in Q4 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Jim Simons held 11,948 shares of Biodesix worth $173K as of Q1 2026.
  • Biodesix was a new Jim Simons position in Q1 2026.
  • Biodesix made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2940 holding.
  • Jim Simons first reported a position in Biodesix in Q2 2022 and has held it in 13 quarters since.
  • Jim Simons's Biodesix position peaked at $551K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.